Subcutaneous Immunoglobulin Therapy In The Chronic Management Of Myasthenia Gravis.
Loading...
Date
2017-02-21
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Faculty of Basic Medical Science - Libyan International Medical University
Abstract
Subcutaneous immunoglobulin therapy has been recently researched and shown to be favorable and to have advantages over intravenous immunoglobulin therapy, in the chronic management of myasthenia gravis. This report aims to discuss the findings of research into this new long term therapy option for myasthenia gravis.
Description
Keywords
Subcutaneous immunoglobulin therapy
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as Attribution 3.0 United States